Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

While InvestingPro data ... sequencing continues to decrease, more researchers and clinicians may be able to incorporate genomic analysis into their work, expanding the overall market for Illumina ...

Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing ...

At AGBT, customers will present data demonstrating unparalleled ... at an unprecedented scale. Enabled on Illumina sequencers and a new multimodal analysis platform, Illumina's spatial technology ...

Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

Illumina and next-gen sequencing (NGS ... ICM is a cloud-based multimodal analysis platform that enables researchers to explore and analyze multiomic data sets, such as genomic, proteomic ...

According to InvestingPro data ... As the cost of sequencing continues to decrease, more researchers and clinicians may be able to incorporate genomic analysis into their work, expanding the overall ...